| 英文名称 |
中文名称 |
CAS号 |
操作 |
| (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate |
(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐 |
376608-71-8 |
详细
|
| 4,6-DICHLORO-5-NITRO-2-PROPYLTHIOPYRIMIDINE |
4,6-二氯-5-硝基-2-丙硫基嘧啶 |
145783-14-8 |
详细
|
| Huperzine A |
石杉碱甲 |
102518-79-6 |
详细
|
| Peramivir |
帕拉米韦 |
229614-55-5 |
详细
|
| (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol |
(3AR,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-醇 |
155899-66-4 |
详细
|
| (1R trans)-2-(3,4-difluorophenyl)cyclopropane amine |
(1R,2S)-REL-2-(3,4-二氟苯基)环丙胺盐酸盐 |
1156491-10-9 |
详细
|
| 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid |
2-[[(3AR,4S,6R,6AS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐 |
376608-65-0 |
详细
|
| 4,6-dichloro-2-propylthiopyrimidine-5-amine |
4,6-二氯 -2-(丙硫基)-5-氨基嘧啶 |
145783-15-9 |
详细
|
| TICAGRELOR |
替卡格雷 |
274693-27-5 |
详细
|
| benzyl N-[(3aR,4S,6R,6aS)-4-hydroxy-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]carbamate |
N-[(3aS,4R,6S,6aR)-四氢-6-羟基-2,2-二甲基-4H-环戊烯并-1,3-二氧戊环-4-基]氨基甲酸苄酯 |
274693-53-7 |
详细
|
| benzyl ((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate |
N-[(3aS, 4R, 6S, 6aR)-四氢-6-(2-羟乙氧基)-2，2-二甲基-4H-环戊烯并-1, 3-二氧杂环戊烷-4-基]苄氧羰酰胺 |
274693-54-8 |
详细
|
| 2-((3aS,4R,6S,6aR)-4-aminotetrahydro-3aH-spiro[cyclopenta[d][1,3]dioxole-2,1'-cyclopentane]-6-yloxy)ethanol oxalic acid salt |
2-((3aS,4R,6S,6aR)-4-氨基四氢-3aH-螺[环戊[d][1,3]二氧戊环-2, 1' -环戊烷]-6-基氧基) 乙醇 草酸盐 |
1402150-20-2 |
详细
|
| (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid |
(2S，5S)-1-((S)-2-((甲氧基羰基)氨基-3-甲基丁酰基)-5-甲基吡咯烷-2-羧酸 |
1335316-40-9 |
详细
|
| Velpatasvir |
维帕他韦 |
1377049-84-7 |
详细
|
| tert-butyl (2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate |
2S,4S)-2-[5-[1,11-二氢-2-[(2S,5S)-1-[(2S)-2-[(甲氧羰基)氨基]-3-甲基-1-氧代丁基]-5-甲基-2-吡咯烷基][2]苯并吡喃并[4',3':6,7]萘并[1,2-d]咪唑-9-基]-1H-咪唑-2-基]-4-(甲氧基甲基)-1-吡咯烷羧酸叔丁酯 |
1378391-45-7 |
详细
|
| 9-Bromo-3-(2-Bromo Acetyl)-10,11-Dihydro-5H-dibenzo(c,g) Chromen-8(9H)-one |
9-溴-3-(2-溴乙酰基)-10,11-二氢-5H-二苯并(C,G) CHROMEN-8(9H)-酮 |
1438383-89-1 |
详细
|
| (2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid |
(2S,4S)-1-(叔丁氧羰基)-4-(甲氧甲基)吡咯啉-2-羧酸 |
1378388-16-9 |
详细
|
| (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylic acid |
(1R,2S)-REL-2-(3,4-二氟苯基)环丙基甲酸 |
220352-36-3 |
详细
|
| Cyclopropanamine,2-(3,4-difluorophenyl)-(1R,2S) -(2R,3R)-2,3-dihydroxybutanedioate (1:1) |
(1R,2S)-2-(3,4-二氟苯基)环丙胺 (2R,3R)-2,3-二羟基丁二酸盐 |
220352-39-6 |
详细
|
| methyl (3aR,4R,6S,6aS)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pentan-3-yl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,2]oxazole-6-carboxylate |
(3aR,4R,6S,6aS)-4-[叔丁氧羰基氨基]-3-(1-乙基丙基)-3a,5,6,6a-四氢-4H-环戊并[d]异恶唑-6-羧酸甲酯 |
229613-93-8 |
详细
|
| calcium (±)-bis[2-hydroxy-4-methylvalerate];Calcium 2-hydroxy-4-methylpentanoate;Calcium 4-methyl-2-hydroxypentanoate;Alpha-Hydroxy-Isocaproate Calcium Salt;HICA |
2-羟基-4-甲基戊酸钙盐;DL-ALPHA-羟基异己酸钙;羟基亮氨酸钙;2-羟基异己酸钙;羟基异己酸钙 |
93778-33-7 |
详细
|
| Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-aMino-6-chloro-2-(propylthio)-4-pyriMidinyl]aMino]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- |
2-(3AR,4S,6R,6AS)-6-(5-胺基-6-氯-2-丙硫基-4-嘧啶基)氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-基]氧]-乙醇 |
376608-74-1 |
详细
|
| Oxiracetam |
奥拉西坦 |
62613-82-5 |
详细
|
| L-carnitine |
左卡尼汀 |
541-15-1 |
详细
|
| 6-Methylpyridine-3-boronic Acid |
2-甲基-5-吡啶硼酸 |
659742-21-9 |
详细
|
| Paramivir intermediate 6-1 |
帕拉米韦中间体6-1 |
229614-05-5 |
详细
|
| Paramivir trihydrate |
帕拉米韦三水合物 |
1041434-82-5 |
详细
|
| Paramivir intermediate 6 |
帕拉米韦中间体6 |
316173-29-2 |
详细
|
| Cyclobutane-1,2-dimethylhydride |
环丁烷-1,2-二甲酸酐 |
4462-96-8 |
详细
|
| Repotrectinib intermediate |
瑞波替尼中间体 |
863453-61-6 |
详细
|
| Paramivir waterless |
帕拉米韦无水物 |
330600-85-6 |
详细
|